Cleared Special

K182790 - Cardio-TriTest v6.5

K182790 is an FDA 510(k) clearance for Cardio-TriTest v6.5, manufactured by Cardio-Phoenix, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Special 510(k) pathway after a 74-day FDA review.

K182790 · Cardio-Phoenix, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
74d
Days
Class 2
Risk

K182790 is an FDA 510(k) clearance for the Cardio-TriTest v6.5. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Cardio-Phoenix, Inc. (Markham, CA). The FDA issued a Cleared decision on December 14, 2018 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K182790

510(k) Number K182790 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2018
Decision Date December 14, 2018
Days to Decision 74 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 125d · This submission: 74d
Pathway characteristics
Modification to existing cleared device.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 577
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K182790.
CardioFlux with Faraday Analytical Cloud
K182571 · Genetesis, Inc. · Mar 2019
ZOLL ECG Analysis Software
K182093 · Zoll Manufacturing Corporation · Jan 2019
COR12 ECG
K183369 · Corscience GmbH & Co. · Dec 2018
CardioBand ECG Event Recorder
K181998 · Samsung Strategy and Innovation Center (Ssic) · Nov 2018
MAC VU360 Resting ECG Analysis System
K173830 · Ge Medical Systems Information Technologies, Inc. · Sep 2018
Universal SmartECG
K173952 · Vectracor, Inc. · Aug 2018
K182790 · Cardio-TriTest v6.5
Download PDF FDA Summary Cardio-Phoenix, Inc.